| Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum MAR Sima Rafati, Alireza Nakhaee, Tahere Taheri, Yasaman Taslimi, Haideh ... Vaccine 23 (28), 3716-3725, 2005 | 172 | 2005 |
| A protective cocktail vaccine against murine cutaneous Leishmaniasis with DNA encoding cysteine proteinases of Leishmania major MVNF S. Rafati, A-H. Salmanian, T. Taheri Vaccine 19, 3369-3375, 2001 | 141 | 2001 |
| Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis A Mizbani, T Taheri, F Zahedifard, Y Taslimi, H Azizi, K Azadmanesh, ... Vaccine 28 (1), 53-62, 2009 | 126 | 2009 |
| Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies A Bolhassani, T Taheri, Y Taslimi, S Zamanilui, F Zahedifard, N Seyed, ... Experimental parasitology 127 (3), 637-645, 2011 | 108 | 2011 |
| Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis A Zadeh-Vakili, T Taheri, Y Taslimi, F Doustdari, AH Salmanian, S Rafati Vaccine 22 (15-16), 1930-1940, 2004 | 81 | 2004 |
| Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, ... PLoS neglected tropical diseases 8 (3), e2751, 2014 | 79 | 2014 |
| Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis N Saljoughian, T Taheri, F Zahedifard, Y Taslimi, F Doustdari, ... PLoS neglected tropical diseases 7 (4), e2174, 2013 | 75 | 2013 |
| Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model M Heidari‐Kharaji, T Taheri, D Doroud, S Habibzadeh, A Badirzadeh, ... Parasite immunology 38 (10), 599-608, 2016 | 74 | 2016 |
| Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in … S Rafati, E Gholami, N Hassani, F Ghaemimanesh, Y Taslimi, T Taheri, ... Vaccine 25 (21), 4159-4169, 2007 | 71 | 2007 |
| Live vaccination tactics: possible approaches for controlling visceral leishmaniasis N Saljoughian, T Taheri, S Rafati Frontiers in immunology 5, 134, 2014 | 68 | 2014 |
| Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8+ T lymphocyte activation S Rafati, A Kariminia, S Seyde-Eslami, M Narimani, T Taheri, M Lebbatard Vaccine 20 (19-20), 2439-2447, 2002 | 65 | 2002 |
| Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites A Badirzadeh, T Taheri, Y Taslimi, Z Abdossamadi, M Heidari-Kharaji, ... PLoS neglected tropical diseases 11 (7), e0005774, 2017 | 57 | 2017 |
| Expression of Cysteine Proteinase Type I and II of Leishmania infantum and their recognition by Sera during Canine and Human Visceral Leishmaniasis NF S. Rafati, A. Nakhaee, T. Taheri, A. Ghashghaii, A-H. salmanian, M ... Experimental Parasitology 103, 143-151, 2003 | 56 | 2003 |
| Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica MH Kharaji, D Doroud, T Taheri, S Rafati Aaps Pharmscitech 17, 1110-1119, 2016 | 52 | 2016 |
| Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model A Katebi, E Gholami, T Taheri, F Zahedifard, S Habibzadeh, Y Taslimi, ... Molecular immunology 67 (2), 501-511, 2015 | 52 | 2015 |
| Immunogenicity of multi-epitope DNA and peptide vaccine candidates based on core, E2, NS3 and NS5B HCV epitopes in BALB/c mice LP Sabet, T Taheri, A Memarnejadian, TM Azad, F Asgari, R Rahimnia, ... Hepatitis monthly 14 (10), 2014 | 48 | 2014 |
| Post-genomics and vaccine improvement for Leishmania N Seyed, T Taheri, S Rafati Frontiers in microbiology 7, 160834, 2016 | 46 | 2016 |
| Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model M Heidari-Kharaji, T Taheri, D Doroud, S Habibzadeh, S Rafati Applied microbiology and biotechnology 100, 7051-7060, 2016 | 45 | 2016 |
| Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against … M Shahbazi, F Zahedifard, T Taheri, Y Taslimi, S Jamshidi, S Shirian, ... PloS one 10 (7), e0132794, 2015 | 44 | 2015 |
| Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally … A Nakhaee, T Taheri, M Taghikhani, M Mohebali, AH Salmanian, N Fasel, ... Veterinary Parasitology 119 (2-3), 107-123, 2004 | 39 | 2004 |
